OpenFilings

Avalo Therapeutics, Inc.

Form10-Q/A

Report Period2024-03-31

Date Filed2024-07-11

Time Filed16:12:56

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-Q/A
EX-31.1
EX-31.2
EX-32.1
Filing on SEC Edgar